Macrophages but not smooth muscle cells undergo benzyloxycarbonyl-Val- Ala-DL-Asp(O-methyl)-fluoromethylketone-induced nonapoptotic cell death depending on receptor-interacting protein 1 expression:: Implications for the stabilization of macrophage-rich atherosclerotic plaques

被引:27
作者
Martinet, W
De Meyer, GRY
Timmermans, JP
Herman, AG
Kockx, MM
机构
[1] Univ Antwerp, Div Pharmacol, B-2610 Antwerp, Belgium
[2] Univ Antwerp, Cell Biol & Histol Lab, Antwerp, Belgium
[3] Gen Hosp Middelheim, Dept Pathol, Antwerp, Belgium
关键词
D O I
10.1124/jpet.106.102970
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Several lines of evidence suggest that macrophages play a key role in atherosclerotic plaque destabilization and rupture. Therefore, selective removal of macrophages from plaques via pharmacological therapy could represent a promising approach to stabilize "vulnerable," rupture-prone lesions. Yet, how macrophages can be eliminated from plaques without influencing other cell types, including smooth muscle cells (SMCs), is unknown. In the present study, we report that benzyloxycarbonyl-Val- Ala-DL-Asp(O-methyl)-fluoromethylketone (z-VAD-fmk), a caspase inhibitor with broad specificity, induces nonapoptotic cell death of J774A.1 and RAW264.7 macrophages but not of SMCs. Cell death was characterized by bulk degradation of long-lived proteins, processing of microtubule-associated protein light chain 3, and cytoplasmic vacuolization, which are all markers of autophagy. However, necrosis also occurred, and the number of necrotic cells rapidly increased during z-VAD-fmk treatment. Primary mouse peritoneal macrophages were resistant to z-VAD-fmk-mediated cell death, but unlike SMCs, they underwent z-VAD-fmk-mediated necrosis after pretreatment with interferon-gamma. Further evidence indicated that the expression level of receptor-interacting protein 1 (RIP1) mediates the sensitivity to z-VAD-fmk. Importantly, upon z-VAD-fmk treatment, J774A.1 macrophages overexpressed and secreted several chemokines and cytokines, including tumor necrosis factor (TNF) alpha. The combination of z-VAD-fmk and TNF alpha, but not TNF alpha alone, induced SMCs necrosis via a mechanism that required RIP1 expression. These results suggest that z-VAD-fmk, despite its selective cell death inducing capacity, would be detrimental for the stability of atherosclerotic plaques due to enlargement of the necrotic core, stimulation of inflammatory responses, and indirect induction of SMC death.
引用
收藏
页码:1356 / 1364
页数:9
相关论文
共 31 条
  • [1] Boyle J. J., 2005, Current Vascular Pharmacology, V3, P63, DOI 10.2174/1570161052773861
  • [2] Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial
    Bresalier, RS
    Sandler, RS
    Quan, H
    Bolognese, JA
    Oxenius, B
    Horgan, K
    Lines, C
    Riddell, R
    Morton, D
    Lanas, A
    Konstam, MA
    Baron, JA
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (11) : 1092 - 1102
  • [3] The autophagosomal-lysosomal compartment in programmed cell death
    Bursch, W
    [J]. CELL DEATH AND DIFFERENTIATION, 2001, 8 (06) : 569 - 581
  • [4] Pleiotropic defects in lymphocyte activation caused by caspase-8 mutations lead to human immunodeficiency
    Chun, HJ
    Zheng, LX
    Ahmad, M
    Wang, J
    Speirs, CK
    Siegel, RM
    Dale, MK
    Puck, J
    Davis, J
    Hall, CG
    Skoda-Smith, S
    Atkinson, TP
    Straus, SE
    Lenardo, MJ
    [J]. NATURE, 2002, 419 (6905) : 395 - 399
  • [5] z-VAD-fmk augmentation of TNFα-stimulated neutrophil apoptosis is compound specific and does not involve the generation of reactive oxygen species
    Cowburn, AS
    White, JF
    Deighton, J
    Walmsley, SR
    Chilvers, ER
    [J]. BLOOD, 2005, 105 (07) : 2970 - 2972
  • [6] Pravastatin treatment increases collagen content and decreases lipid content, inflammation, metalloproteinases, and cell death in human carotid plaques - Implications for plaque stabilization
    Crisby, M
    Nordin-Fredriksson, G
    Shah, PK
    Yano, J
    Zhu, J
    Nilsson, J
    [J]. CIRCULATION, 2001, 103 (07) : 926 - 933
  • [7] Death by design: apoptosis, necrosis and autophagy
    Edinger, AL
    Thompson, CB
    [J]. CURRENT OPINION IN CELL BIOLOGY, 2004, 16 (06) : 663 - 669
  • [8] Caspase inhibitors
    Ekert, PG
    Silke, J
    Vaux, DL
    [J]. CELL DEATH AND DIFFERENTIATION, 1999, 6 (11) : 1081 - 1086
  • [9] Ras is involved in the negative control of autophagy through the class IPI3-kinase
    Furuta, S
    Hidaka, E
    Ogata, A
    Yokota, S
    Kamata, T
    [J]. ONCOGENE, 2004, 23 (22) : 3898 - 3904
  • [10] Mechanisms of disease - Inflammation, atherosclerosis, and coronary artery disease
    Hansson, GK
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (16) : 1685 - 1695